From: Role of nutraceuticals during the transition period of dairy cows: a review
Nutraceutical | Treatment | Period | Tissue/Cells | Main outcome | Reference |
---|---|---|---|---|---|
Live yeast | 1 × 1010/d/head | From − 21 to 21 d relative to calving | Rumen | Dry cows responded rapidly to live yeast with Greater abundance of TLR4 and IL10 prepartum | [124] |
 |  | Colon | Greater abundance of DEFB1 | ||
Live yeast | 2.5 g/d/head precalving and 10 g/d/head postcalving | From −14 to 70 d relative to calving | Liver | Greater glycogen | [109] |
 |  | Plasma | Greater phosphorous concentration | ||
Saccharomices cereviseae fermentation product | 19 g/d/head | From 28 to 42 d relative to calving | Rumen | Greater abundance of IGFBP6 In cows fed a high-starch diet increased abundance of BDH2 | [122] |
19 g/d/head | From − 28 to 42 d relative to calving | Plasma | Lower haptoglobin at 7 d postpartum | [115] | |
19 g/d/head | From −29 to 42 d relative to calving | Liver | Tendency to increase PCK1 mRNA abundance | [114] | |
 |  | Liver | Decreased cholesterol | ||
 |  | Plasma | Increased cholesterol | ||
56 or 112 g/d/head | From −4 weeks to 4 weeks relative to calving | Plasma | Higher glucose between partum and + 3 d Higher urea at partum and + 1 d. With the dosage of 112 g/d/head, higher BHB at 3 d postpartum Lower cortisol | [116] |